REPLIGEN CORP Other Current Liabilities
REPLIGEN CORP (RGEN) had Other Current Liabilities of $377.18 thousand as of 2014-06-30, per its 10-Q filed 2014-08-11.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2014-08-11
- 2014-06-30: Other Liabilities, Current $377.18K.
- 2014-03-31: Other Liabilities, Current $1.31M.
- 2013-12-31: Other Liabilities, Current $1.20M.
- 2013-09-30: Other Liabilities, Current $1.16M.
| Period end | Other Liabilities, Current |
|---|---|
| 2014-06-30 | $377.18K 10-Q · filed 2014-08-11 |
| 2014-03-31 | $1.31M 10-Q · filed 2014-05-09 |
| 2013-12-31 | $1.20M 10-Q · filed 2014-08-11 |
| 2013-09-30 | $1.16M 10-Q · filed 2013-11-08 |
| 2013-06-30 | $1.11M 10-Q · filed 2013-08-07 |
| 2013-03-31 | $1.09M 10-Q · filed 2013-05-07 |
| 2012-12-31 | $1.38M 10-K · filed 2014-03-14 |
| 2011-12-31 | $35.00K 10-K · filed 2013-03-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| ImmunityBio, Inc. (IBRX) | United States | $9.157B | -9.29 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| HALOZYME THERAPEUTICS, INC. (HALO) | United States | $13.083B | 21.59 |
| NEUROCRINE BIOSCIENCES INC (NBIX) | United States | $14.131B | 24.25 |
| EXELIXIS, INC. (EXEL) | United States | $14.358B | 16.15 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |